BIO Logo

Bio-Rad Laboratories, Inc. (BIO) 

NYSE
Market Cap
$9.18B
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
434 of 960
Rank in Industry
55 of 120

Largest Insider Buys in Sector

BIO Stock Price History Chart

BIO Stock Performance

About Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, …

Insider Activity of Bio-Rad Laboratories, Inc.

Over the last 12 months, insiders at Bio-Rad Laboratories, Inc. have bought $0 and sold $0 worth of Bio-Rad Laboratories, Inc. stock.

On average, over the past 5 years, insiders at Bio-Rad Laboratories, Inc. have bought $0 and sold $6.29M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 500 shares for transaction amount of $109,792 was made by HINCKLEY GREGORY K (director) on 2017‑05‑26.

List of Insider Buy and Sell Transactions, Bio-Rad Laboratories, Inc.

2023-12-12SaleEVP, President, CDG
1,200
0.0042%
$299.16$358,992+9.96%
2023-11-28SaleEVP, GBL Commercial Operations
642
0.0022%
$305.10$195,874+5.79%
2023-08-30SaleEVP, General Counsel & Sec
2,350
0.0081%
$395.60$929,667-20.17%
2023-08-23SaleEVP, General Counsel & Sec
300
0.001%
$384.69$115,407-17.82%
2023-06-15SaleEVP, GBL Commercial Operations
500
0.0017%
$379.39$189,695-13.92%
2023-06-06SaleSVP, Chief Accounting Officer
198.35
0.0007%
$368.30$73,053-11.34%
2023-03-08SaleEVP, General Counsel & Sec
1,746
0.006%
$486.43$849,300-24.18%
2022-11-10SaleSVP, Chief Accounting Officer
379.38
0.0013%
$421.87$160,051-6.43%
2022-08-05SaleSVP, Chief Accounting Officer
518
0.0017%
$537.00$278,166-21.06%
2021-11-12SaleExecutive Vice President
4,800
0.016%
$750.05$3.6M-29.26%
2021-11-11SaleExecutive Vice President
1,546
0.0052%
$749.00$1.16M-28.86%
2021-09-03SaleEVP, Chief Financial Officer
270
0.0009%
$820.06$221,416-28.93%
2021-09-02SaleEVP, Chief Financial Officer
540
0.0018%
$828.00$447,121-29.43%
2021-09-01SaleEVP, Chief Operating Officer
2,000
0.0067%
$813.10$1.63M-28.42%
2021-08-26SaleExecutive Vice President
600
0.002%
$792.58$475,548-26.32%
2021-08-09SaleEVP, GBL Commercial Operations
3,000
0.01%
$754.93$2.26M-19.26%
2021-08-04SaleEVP, General Counsel & Sec
327
0.0011%
$760.26$248,605-19.02%
2021-08-04SaleEVP, Chief Financial Officer
2,300
0.0076%
$751.84$1.73M-19.02%
2021-02-19SaleEVP, General Counsel & Sec
923.11
0.0021%
$432.07$398,851+4.93%
2020-12-15SaleEVP, GBL Commercial Operations
374
0.0012%
$580.67$217,171+9.55%

Insider Historical Profitability

<0.0001%
SCHWARTZ ALICE Ndirector, 10 percent owner
1806651
6.4452%
$327.3812<0.0001%
SCHWARTZ DAVIDChairman of the Board
8753
0.0312%
$327.3810<0.0001%
HUTTON RONALD WVice President and Treasurer
4140
0.0148%
$327.38117<0.0001%
HINCKLEY GREGORY Kdirector
500
0.0018%
$327.3810+11%
STARK JAMES RVP, Corporate Controller
0
0%
$327.38127<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
The Vanguard Group$837.47M8.492.42M+1.32%+$10.88M0.02
BlackRock$511.85M5.191.48M+0.93%+$4.72M0.01
Veritas Asset Management LLP$396.75M4.021.15M+5.93%+$22.21M2.88
State Street$302.18M3.06873,675-0.14%-$428,532.930.01
EARNEST Partners$178.09M1.81514,906+30.81%+$41.94M0.82
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.